35,000 diabetes patients given eye tests in Almeria

0

MORE THAN 35,000 people with diabetes have undergone an eye test to detect early signs of blindness brought on by the disease.

The total of 35,344 people tested for early diabetic retinopathy means that, since its implementation in 2006, the coverage of the programme has been growing progressively, reaching 95% of the target population of patients with diabetes.

The diabetic retinopathy given to the patients is characterised by different lesions that affect the retina and is one of the leading complications of diabetes, which can lead to blindness. The risk of vision loss in people with diabetes is 25 times higher than in the general population.

It is estimated that between 15 and 30 percent of people with diabetes have retinopathy and that the risk of blindness can be reduced by more than 60% if it is diagnosed early.

51,000 Almerians, 27,900 are men and more than 23,300 women, are suspected of having the illness.

64,741 retinographies have been performed in Almeria since 2006. The Diabetic Retinopathy Early Detection Program, launched by the Ministry of Health as part of the Comprehensive Diabetes Plan, encourages all diabetes patients to be checked.

LEAVE A COMMENT

Please enter your comment!
Please enter your name here

We welcome comments from readers on our website and across our social networks. We invite you to discuss issues and share your views and we encourage robust debate and criticism provided it is civil.

However we reserve the right to reject or edit comments that:

• Contain offensive language
• Include personal attacks of any kind
• Are likely to offend or target any ethnic, racial, nationality or religious group
• Are homophobic, transphobic, sexist, offensive or obscene
• Contain spam or include links to other sites
• Are clearly off topic
• Impersonate an individual or organisation, are fraudulent, defamatory of any person, threatening or invasive of another’s privacy or otherwise illegal
• Are trolling or threatening
• Promote, advertise or solicit the sale of any goods or services

You grant us a non-exclusive, royalty-free, perpetual, worldwide licence to republish any material you submit to us, without limitation, in any format.